Rajesh Shrestha - Mar 31, 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role: Pres., New Markets & CBO
Signature: Richard A. Cross, as Attorney-in-Fact, for Rajesh Shrestha
Stock symbol: ALHC
Transactions as of: Mar 31, 2022
Transactions value $: -$158,962
Form type: 4
Date filed: 4/1/2022, 07:21 PM
Previous filing: Aug 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALHC	Common Stock	Sale	-$159K	-14.2K	-7.71%	$11.18	170K	Mar 31, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Rajesh Shrestha is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
F2	The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.